Next Article in Journal
Distal Renal Tubular Acidosis in Patients with Autoimmune Diseases—An Update on Pathogenesis, Clinical Presentation and Therapeutic Strategies
Next Article in Special Issue
Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
Previous Article in Journal
Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre Study
Previous Article in Special Issue
MiRNAs in Systemic Sclerosis Patients with Pulmonary Arterial Hypertension: Markers and Effectors
 
 
Article

Article Versions Notes

Biomedicines 2022, 10(9), 2129; https://doi.org/10.3390/biomedicines10092129
Action Date Notes Link
article xml file uploaded 31 August 2022 08:40 CEST Original file -
article xml uploaded. 31 August 2022 08:40 CEST Update https://www.mdpi.com/2227-9059/10/9/2129/xml
article pdf uploaded. 31 August 2022 08:40 CEST Version of Record https://www.mdpi.com/2227-9059/10/9/2129/pdf
article html file updated 31 August 2022 08:41 CEST Original file -
article html file updated 28 February 2023 11:36 CET Update https://www.mdpi.com/2227-9059/10/9/2129/html
Back to TopTop